{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:57:27Z","timestamp":1720612647100},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJWH"],"DOI":"10.2147\/ijwh.s18209","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T22:50:30Z","timestamp":1334184630000},"page":"167","source":"Crossref","is-referenced-by-count":5,"title":["Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation"],"prefix":"10.2147","author":[{"given":"Plamen","family":"Kinov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Boyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,4]]},"container-title":["International Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=12508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:12:54Z","timestamp":1477851174000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/clinical-utility-of-risedronate-in-postmenopausal-osteoporosis-patient-peer-reviewed-article-IJWH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ijwh.s18209","relation":{},"ISSN":["1179-1411"],"issn-type":[{"value":"1179-1411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}